Advertisement
Novara — A Smarter Way to Access Global Markets
Markets desk·updated through the day

Earnings

Nomad Foods shares rise 4.6% after insider purchases, strong Q2 results
EquitiesArticle

Nomad Foods shares rise 4.6% after insider purchases, strong Q2 results

Nomad Foods stock gained on insider buying and better-than-expected Q2 earnings, even as broader market benchmarks diverged. Shares remain 23% below their 52-week high.

Markets Desk · 24 Aug 2026
Global market agenda: Key events for Aug 24, 2026
EquitiesArticle

Global market agenda: Key events for Aug 24, 2026

PDD Holdings reports quarterly earnings; U.S. CFNA index data due alongside other global economic releases.

Markets Desk · 24 Aug 2026
Swiss economic calendar: August 24-31, 2026
CompaniesArticle

Swiss economic calendar: August 24-31, 2026

Over 30 Swiss companies and institutions to release half-year earnings and key economic data, including UBS-CFA Index, KOF barometer and SBB H1 results.

Markets Desk · 24 Aug 2026
Ventia posts record 9.4% EBITDA margin in HY26 as revenue declines 4.7%
EquitiesArticle

Ventia posts record 9.4% EBITDA margin in HY26 as revenue declines 4.7%

Australia’s Ventia Services Group reported a 9.4% EBITDA margin in the first half of 2026, up 1.1 percentage points year-over-year, despite a 4.7% drop in revenue to $2.9 billion. The company reaffirmed full-year NPATA growth guidance of 7–10%.

Markets Desk · 24 Aug 2026
Aussie Broadband shares drop 4% after FY26 results despite EBITDA growth
EquitiesArticle

Aussie Broadband shares drop 4% after FY26 results despite EBITDA growth

Revenue rose 9.2% to AUD 1.30 billion while underlying EBITDA climbed 20% to AUD 165.3 million, but shares fell on margin concerns and regulatory headwinds. FY27 EBITDA guidance set at AUD 205-215 million.

Markets Desk · 24 Aug 2026
Organon shares under pressure as Q2 earnings loom after Q1 miss
EarningsArticle

Organon shares under pressure as Q2 earnings loom after Q1 miss

Drugmaker faces investor scrutiny as analysts project sequential earnings rebound despite YoY declines. Sun Pharma’s $11.75 billion bid looms over the company’s near-term outlook.

Markets Desk · 23 Aug 2026
Nvidia fiscal Q2 2027 earnings: $92B revenue seen, margin focus ahead
EquitiesArticle

Nvidia fiscal Q2 2027 earnings: $92B revenue seen, margin focus ahead

Analysts expect Nvidia to report $91.9B in revenue for fiscal Q2 2027, with gross margins and China demand among key watchpoints after four straight upside surprises.

Markets Desk · 22 Aug 2026
Key earnings to watch next week beyond Nvidia
EarningsArticle

Key earnings to watch next week beyond Nvidia

PDD, Intuit, Salesforce and CrowdStrike report alongside Marvell Technology and consumer-health names. Earnings reflect AI demand, Chinese spending and beaten-down software valuations.

Markets Desk · 22 Aug 2026
Dino Polska Q2 2026 EPS beats estimates as deflation weighs on sales
EquitiesArticle

Dino Polska Q2 2026 EPS beats estimates as deflation weighs on sales

Polish grocery chain posts 4.9% EPS beat despite 0.7% revenue miss, with like-for-like sales growth slowing to 0.3% amid food price deflation. Shares rise 5.8%.

Markets Desk · 22 Aug 2026
SATS Q1 FY27 revenue rises 11% as margins remain under pressure
EquitiesArticle

SATS Q1 FY27 revenue rises 11% as margins remain under pressure

Singapore-based aviation services provider posts S$1.68 billion in revenue, up 11.3% year-over-year, while EBITDA margin contracts 0.9 percentage points to 17.3%.

Markets Desk · 22 Aug 2026
BizLink posts Q2 2026 revenue, EPS beat on margin recovery
EarningsArticle

BizLink posts Q2 2026 revenue, EPS beat on margin recovery

Taiwanese connector maker BizLink International reported a 37% YoY revenue jump and record EPS, citing robust AI-driven demand and sequential margin expansion. Shares rose 1.1% on the news.

Markets Desk · 22 Aug 2026
NIBE posts six straight quarters of growth, lifts Q2 2026 outlook
EquitiesArticle

NIBE posts six straight quarters of growth, lifts Q2 2026 outlook

Swedish industrial group reports 8.7% organic revenue growth and upgrades full-year margin guidance after strong second-quarter results.

Markets Desk · 22 Aug 2026
Catella Q2 2026 revenue drops 47% as disposal income fades, shares fall 3.7%
EarningsArticle

Catella Q2 2026 revenue drops 47% as disposal income fades, shares fall 3.7%

Swedish financial services group Catella reported a 47% year-on-year decline in Q2 2026 revenue to SEK 400 million, with underlying net revenue rising 5% to SEK 310 million. Shares slipped 3.7% after the earnings call.

Markets Desk · 21 Aug 2026
HKEX posts record H1 2026 profit on trading surge, dividend hike
EquitiesArticle

HKEX posts record H1 2026 profit on trading surge, dividend hike

Hong Kong Exchanges and Clearing reported a 24% rise in H1 2026 profit as trading volumes hit records, with EPS beating estimates by 18%. First interim dividend raised to HKD 7.43 per share.

Markets Desk · 21 Aug 2026
Novonesis shares surge 9% after Q2 results, higher 2026 guidance and €1bn buyback
EquitiesArticle

Novonesis shares surge 9% after Q2 results, higher 2026 guidance and €1bn buyback

Danish biosolutions firm posts 9% organic sales growth in Q2, beats estimates, raises 2026 outlook and launches inaugural €1bn share repurchase program.

Markets Desk · 21 Aug 2026
Novonesis lifts 2026 outlook, shares surge 8.5% on earnings update
EquitiesArticle

Novonesis lifts 2026 outlook, shares surge 8.5% on earnings update

The Danish biosolutions firm raised its full-year organic growth target to 7%-8% and announced a €1 billion buyback program through 2029. Shares jumped 8.5% to $449.50 amid strong H1 sales and EBITDA growth.

Markets Desk · 21 Aug 2026
Mayr-Melnhof raises profit target to over €330 mln by 2027
EarningsArticle

Mayr-Melnhof raises profit target to over €330 mln by 2027

Austrian packaging group lifts full-year guidance after strong H1 2026 earnings and Fit-For-Future program delivery. Shares trade near €80.80.

Markets Desk · 21 Aug 2026
Norse Atlantic posts $132 mln Q2 loss as revenue falls short of forecast
EquitiesArticle

Norse Atlantic posts $132 mln Q2 loss as revenue falls short of forecast

Airline’s second-quarter revenue of $132 million missed a $1.65 billion target, while EBITDA widened to negative $8 million. Stock near 52-week low after bridge loan repayment.

Markets Desk · 21 Aug 2026
Global economic calendar: August 20, 2026 — earnings, inflation and central bank updates
MacroArticle

Global economic calendar: August 20, 2026 — earnings, inflation and central bank updates

AEGON, Alibaba and Walmart among companies reporting quarterly results; Germany releases producer prices and trade data alongside Sweden’s Riksbank rate decision.

Markets Desk · 21 Aug 2026
Santacruz Silver posts 55% revenue jump in Q2 2026, AISC falls 24%
EquitiesArticle

Santacruz Silver posts 55% revenue jump in Q2 2026, AISC falls 24%

Silver miner Santacruz Silver Mining reported $113.46 million in revenue for Q2 2026, up 55% year-over-year, while all-in sustaining costs dropped to $21.87 per ounce. Net income fell to $2 million amid non-cash charges tied to exchange-rate shifts in Bolivia.

Markets Desk · 21 Aug 2026
Sonic Healthcare FY 2026 earnings miss forecasts, shares slide 9.9%
EarningsArticle

Sonic Healthcare FY 2026 earnings miss forecasts, shares slide 9.9%

The Australian pathology group posted 13% revenue growth but EPS fell short of expectations, prompting a near‑10% drop in its stock and a modest dividend increase.

Markets Desk · 21 Aug 2026
Swiss economic calendar: Q2 earnings, macro data due Aug 21-28
EquitiesArticle

Swiss economic calendar: Q2 earnings, macro data due Aug 21-28

Investors face a packed week of Swiss half-year results, Q2 earnings and key macro indicators including GDP, tourism and labor data.

Markets Desk · 21 Aug 2026
MAAS Group posts 37% EBITDA rise, lifts buyback plan to 20% of shares
EquitiesArticle

MAAS Group posts 37% EBITDA rise, lifts buyback plan to 20% of shares

Underlying EBITDA surged 37% to AUD 300.3 million in H2 2026, while revenue climbed 27% to AUD 1.3 billion. The group expanded its buyback program to 20% of issued capital over 12 months.

Markets Desk · 21 Aug 2026
Sonic Healthcare posts 13% revenue rise but shares drop on FY2026 outlook
EquitiesArticle

Sonic Healthcare posts 13% revenue rise but shares drop on FY2026 outlook

Australia’s largest pathology provider reported A$10.9 billion in revenue for FY2026, up 13% year-over-year, but its stock fell 9.2% after missing earnings expectations and flagging margin pressures in key markets.

Markets Desk · 21 Aug 2026